320 related articles for article (PubMed ID: 34025668)
1. CXCL8 Associated Dendritic Cell Activation Marker Expression and Recruitment as Indicators of Favorable Outcomes in Colorectal Cancer.
Li E; Yang X; Du Y; Wang G; Chan DW; Wu D; Xu P; Ni P; Xu D; Hu Y
Front Immunol; 2021; 12():667177. PubMed ID: 34025668
[TBL] [Abstract][Full Text] [Related]
2. Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8-CXCR2 Axis.
Ogawa R; Yamamoto T; Hirai H; Hanada K; Kiyasu Y; Nishikawa G; Mizuno R; Inamoto S; Itatani Y; Sakai Y; Kawada K
Clin Cancer Res; 2019 May; 25(9):2887-2899. PubMed ID: 30705034
[TBL] [Abstract][Full Text] [Related]
3. Interferon gamma inhibits CXCL8-CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer.
Zhang M; Huang L; Ding G; Huang H; Cao G; Sun X; Lou N; Wei Q; Shen T; Xu X; Cao L; Yan Q
J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32051287
[TBL] [Abstract][Full Text] [Related]
4. The Crucial Role of CXCL8 and Its Receptors in Colorectal Liver Metastasis.
Bie Y; Ge W; Yang Z; Cheng X; Zhao Z; Li S; Wang W; Wang Y; Zhao X; Yin Z; Li Y
Dis Markers; 2019; 2019():8023460. PubMed ID: 31827643
[TBL] [Abstract][Full Text] [Related]
5. Targeted Deletion of CXCR2 in Myeloid Cells Alters the Tumor Immune Environment to Improve Antitumor Immunity.
Yang J; Yan C; Vilgelm AE; Chen SC; Ayers GD; Johnson CA; Richmond A
Cancer Immunol Res; 2021 Feb; 9(2):200-213. PubMed ID: 33177110
[TBL] [Abstract][Full Text] [Related]
6. An updated review on the role of the CXCL8-CXCR1/2 axis in the progression and metastasis of breast cancer.
Mishra A; Suman KH; Nair N; Majeed J; Tripathi V
Mol Biol Rep; 2021 Sep; 48(9):6551-6561. PubMed ID: 34426905
[TBL] [Abstract][Full Text] [Related]
7. Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy.
Han ZJ; Li YB; Yang LX; Cheng HJ; Liu X; Chen H
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011369
[TBL] [Abstract][Full Text] [Related]
8. Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression.
Gabellini C; Trisciuoglio D; Desideri M; Candiloro A; Ragazzoni Y; Orlandi A; Zupi G; Del Bufalo D
Eur J Cancer; 2009 Sep; 45(14):2618-27. PubMed ID: 19683430
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-36α inhibits colorectal cancer metastasis by enhancing the infiltration and activity of CD8
Wei X; Yao Y; Wang X; Sun J; Zhao W; Qiu L; Zhai W; Qi Y; Gao Y; Wu Y
Int Immunopharmacol; 2021 Nov; 100():108152. PubMed ID: 34555640
[TBL] [Abstract][Full Text] [Related]
10. Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer.
Nasser MW; Raghuwanshi SK; Grant DJ; Jala VR; Rajarathnam K; Richardson RM
J Immunol; 2009 Sep; 183(5):3425-32. PubMed ID: 19667085
[TBL] [Abstract][Full Text] [Related]
11. Probing the role of CXC motif in chemokine CXCL8 for high affinity binding and activation of CXCR1 and CXCR2 receptors.
Joseph PR; Sarmiento JM; Mishra AK; Das ST; Garofalo RP; Navarro J; Rajarathnam K
J Biol Chem; 2010 Sep; 285(38):29262-9. PubMed ID: 20630874
[TBL] [Abstract][Full Text] [Related]
12. Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8.
Sukkurwala AQ; Martins I; Wang Y; Schlemmer F; Ruckenstuhl C; Durchschlag M; Michaud M; Senovilla L; Sistigu A; Ma Y; Vacchelli E; Sulpice E; Gidrol X; Zitvogel L; Madeo F; Galluzzi L; Kepp O; Kroemer G
Cell Death Differ; 2014 Jan; 21(1):59-68. PubMed ID: 23787997
[TBL] [Abstract][Full Text] [Related]
13. METTL3 Inhibits Antitumor Immunity by Targeting m
Chen H; Pan Y; Zhou Q; Liang C; Wong CC; Zhou Y; Huang D; Liu W; Zhai J; Gou H; Su H; Zhang X; Xu H; Wang Y; Kang W; Kei Wu WK; Yu J
Gastroenterology; 2022 Oct; 163(4):891-907. PubMed ID: 35700773
[TBL] [Abstract][Full Text] [Related]
14. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis.
Khan MN; Wang B; Wei J; Zhang Y; Li Q; Luan X; Cheng JW; Gordon JR; Li F; Liu H
Oncotarget; 2015 Aug; 6(25):21315-27. PubMed ID: 26087179
[TBL] [Abstract][Full Text] [Related]
15. Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells.
Maxwell PJ; Neisen J; Messenger J; Waugh DJ
Oncotarget; 2014 Jul; 5(13):4895-908. PubMed ID: 24970800
[TBL] [Abstract][Full Text] [Related]
16. The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models.
Ning Y; Labonte MJ; Zhang W; Bohanes PO; Gerger A; Yang D; Benhaim L; Paez D; Rosenberg DO; Nagulapalli Venkata KC; Louie SG; Petasis NA; Ladner RD; Lenz HJ
Mol Cancer Ther; 2012 Jun; 11(6):1353-64. PubMed ID: 22391039
[TBL] [Abstract][Full Text] [Related]
17. CXCL8 induces M2 macrophage polarization and inhibits CD8
Shao Y; Lan Y; Chai X; Gao S; Zheng J; Huang R; Shi Y; Xiang Y; Guo H; Xi Y; Yang L; Yang T
FASEB J; 2023 Oct; 37(10):e23173. PubMed ID: 37665572
[TBL] [Abstract][Full Text] [Related]
18. Probiotics improve re-epithelialization of scratches infected by Porphyromonas gingivalis through up-regulating CXCL8-CXCR1/CXCR2 axis.
Albuquerque-Souza E; Ishikawa KH; Amado PP; Nicoli JR; Holzhausen M; Mayer MPA
Anaerobe; 2021 Dec; 72():102458. PubMed ID: 34547426
[TBL] [Abstract][Full Text] [Related]
19. Role of MIF/CXCL8/CXCR2 signaling in the growth of nasopharyngeal carcinoma tumor spheres.
Lo MC; Yip TC; Ngan KC; Cheng WW; Law CK; Chan PS; Chan KC; Wong CK; Wong RN; Lo KW; Ng WT; Lee WM; Tsao SW; Kwong LW; Lung ML; Mak NK
Cancer Lett; 2013 Jul; 335(1):81-92. PubMed ID: 23403077
[TBL] [Abstract][Full Text] [Related]
20. The chemokine receptors CXCR1 and CXCR2 couple to distinct G protein-coupled receptor kinases to mediate and regulate leukocyte functions.
Raghuwanshi SK; Su Y; Singh V; Haynes K; Richmond A; Richardson RM
J Immunol; 2012 Sep; 189(6):2824-32. PubMed ID: 22869904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
